SEVERANCE AGREEMENTSeverance Agreement • January 26th, 2024 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
Contract Type FiledJanuary 26th, 2024 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT is made as of March 10, 2023 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Cenk Sumen (the "Executive").